Investors in Andon Health Co.Ltd(002432) (002432) also made a lot of money because of the soaring stock price. more investors say “make a lot of money and want to donate money”! On January 18, Andon Health Co.Ltd(002432) closed at the limit.
The trading market showed that Andon Health Co.Ltd(002432) opened 2.64% higher in the morning of January 18, and fell after the stock price briefly rose slightly. At the afternoon opening of the day, Andon Health Co.Ltd(002432) quickly fell by the limit. As of the closing of the day, Andon Health Co.Ltd(002432) closed at 74.53 yuan / share, a decrease of 10%. Andon Health Co.Ltd(002432) on January 18, the highest price was 88.88 yuan / share. according to China stock market news, the total turnover of Andon Health Co.Ltd(002432) on January 18 was 8.14 billion yuan, with a total market value of 35.67 billion yuan.
It is worth mentioning that since November 15, 2021, Andon Health Co.Ltd(002432) share price has soared all the way like a rocket. According to China stock market news, from November 15, 2021 to January 17, 2022, Andon Health Co.Ltd(002432) share price has soared by more than 11 times. Some investors frankly say that “make a lot of money and want to donate money”!
After the stock price plummeted, many netizens joked that “those who make money in front want to donate money to the company, but those who come in later can only donate bone slag” , and some netizens issued “do you still donate money?” My soul. Others said that “small scattered donations” may become the same hot stem as “turning off the lights and eating noodles”.
According to media reports, on the news side, Andon Health Co.Ltd(002432) “trading myth” has come to an end temporarily, which may be related to its overseas kit orders.
It was previously reported that Andon Health Co.Ltd(002432) since November 8, 2021, the stock price has started to rise. It announced on November 8 that the company learned in the early morning of November 6, 2021 Beijing time that, authorized by the U.S. Food and drug administration, the covid-19 self-test kit of ihealth, the U.S. subsidiary of the company, has been authorized for emergency use and can be sold in the United States and countries / regions recognized by the U.S. EUA during the U.S. public health emergency.
Recently, on January 14, Andon Health Co.Ltd(002432) announced a procurement contract worth about $1.275 billion between its subsidiary ihealth and the U.S. Army contract management command. In fact, since December 2021, the cumulative amount of orders signed between ihealth and U.S. officials has reached $1.6 billion, equivalent to about 10 billion yuan, five times higher than the annual revenue of Andon Health Co.Ltd(002432) 2020.
But soon, Andon Health Co.Ltd(002432) issued a supplementary announcement saying that “the U.S. government has the right to terminate the contract at any time due to its own factors”. In other words, this high order may be cancelled by the US at any time, and “no reason is needed”. All losses caused by the cancellation of the order will be borne by Andon Health Co.Ltd(002432) .
Another fact that cannot be ignored is that the performance of Andon Health Co.Ltd(002432) in 2021 is not outstanding . Under the covid-19 epidemic in 2020, Andon Health Co.Ltd(002432) got out of the loss state in the previous two years, but by 2021, the epidemic will no longer be good. In the first three quarters of 2021, Andon Health Co.Ltd(002432) revenue was about 790 million yuan, a year-on-year decrease of 50%.
On January 18, Andon Health Co.Ltd(002432) issued a prompt announcement again, saying that at present, the company’s share price is at an all-time high, which does not rule out the risk of falling in the future. The company hereby reminds investors that the company will strictly implement the relevant provisions on information disclosure of listed companies and fulfill the obligation of information disclosure in time. It also takes this opportunity to remind investors again that there are many rumors on the Internet platform. Investors are requested to take the information officially released by the company as the standard and do not calculate the company’s performance and future trend without basis. There are many factors affecting the stock price of the secondary market, and the development of the epidemic in the United States in the future is still uncertain. The sales of kit products are affected by many factors. Investors are invited to pay attention to investment risks and invest rationally.
Affected by the limit of Andon Health Co.Ltd(002432) , on the 18th, covid-19 detection concept stocks fell . Dian Diagnostics Group Co.Ltd(300244) fell by more than 8%, and Guangzhou Wondfo Biotech Co.Ltd(300482) , Beijing Hotgen Biotech Co.Ltd(688068) all fell by more than 10%.
